Figure 2: Effect of phospho-TH (pSer19, pSer31 and pSer40) levels in the SN, VTA and LC following neonatal peripheral LPS challenge.
From: Early life peripheral lipopolysaccharide challenge reprograms catecholaminergic neurons
(a) Representative immunoblots for pSer19, pSer31, pSer40 and β-actin from the SN, VTA and LC comparing the effects of Saline and LPS treatment are shown for two different animals for each treatment. The results of pSer19, pSer31 and pSer40 levels were calculated relative to β-actin levels from the (b) SN, (c) VTA and (d) LC. Values for Saline and LPS groups were expressed as fold increase of the mean ± SEM relative to the mean of the Saline group. *p < 0.05, **p < 0.01, ***p < 0.001.
